Clinical Study
Clinical Outcomes of Surgical Treatments for Primary Malignant Bone Tumors Arising in the Acetabulum
Table 1
Patient characteristics for the entire study population and surgical/oncological outcome.
| | Description | Number |
| | Patients | | | Male 13, female 5 | Total 18 | | Age (at diagnosis) | 41 years (8–69) | | Tumor size | 11.7 cm (7–20) | | Diagnosis | | | Osteosarcoma | 8 | | Chondrosarcoma | 5 | | MFH of bone | 2 | | Ewing sarcoma | 2 | | Fibrosarcoma of bone | 1 | | Neoadjuvant therapy | | | Polychemotherapy | 11 | | Radiotherapy | 0 | | Adjuvant therapy | | | Polychemotherapy | 9 | | Radiotherapy | 1 | | Follow-up | 62 months (8–155) | | Resected area (Enneking classification) | | | PII | 2 | | PI-II | 4 | | PII-III | 8 | | PI-II-III | 4 | | Surgical outcome | | | Wide margin | 17 | | Marginal margin | 0 | | Intralesional margin | 1 | | Oncological outcome | | | No evidence of disease (NED) | 11 | | Alive with disease (AWD) | 2 | | Dead of disease (DOD) | 5 | | Prognosis | | | Overall survival (five years) | 67.2% |
|
|